Opinion - Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?

被引:348
作者
Sotiriou, Christos
Piccart, Martine J.
机构
[1] Inst Jules Bordet, Translat Res Unit, B-1000 Brussels, Belgium
[2] Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
关键词
D O I
10.1038/nrc2173
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The advent of microarray technology has enabled scientists to simultaneously investigate the expression of thousands of genes. Gene-expression profiling studies have provided a molecular classification of breast cancer into clinically relevant subtypes, new tools to predict disease recurrence and response to different treatments, and new insights into various oncogenic pathways and the process of metastatic progression. Here we describe the state of the art of gene-expression studies in breast cancer, and consider both their current limitations and future promises. We also discuss the potential of molecular signatures to have an impact on individual breast cancer patient management, and ultimately to accelerate the transition between empirical and tailored medicine.
引用
收藏
页码:545 / 553
页数:9
相关论文
共 83 条
[1]   DNA arrays as predictors of efficacy of adjuvant/neoadjuvant chemotherapy in breast cancer patients: Current data and issues on study design [J].
Andre, Fabrice ;
Mazouni, Chafika ;
Hortobagyi, Gabriel N. ;
Pusztai, Lajos .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2006, 1766 (02) :197-204
[2]   Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer [J].
Ayers, M ;
Symmans, WF ;
Stec, J ;
Damokosh, AI ;
Clark, E ;
Hess, K ;
Lecocke, M ;
Metivier, J ;
Booser, D ;
Ibrahim, N ;
Valero, V ;
Royce, M ;
Arun, B ;
Whitman, G ;
Ross, J ;
Sneige, N ;
Hortobagyi, GN ;
Pusztai, L .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) :2284-2293
[3]   Spotted long oligonucleotide arrays for human gene expression analysis [J].
Barczak, A ;
Rodriguez, MW ;
Hanspers, K ;
Koth, LL ;
Tai, YC ;
Bolstad, BM ;
Speed, TP ;
Erle, DJ .
GENOME RESEARCH, 2003, 13 (07) :1775-1785
[4]   Validation of a novel, fully integrated and flexible microarray benchtop facility for gene expression profiling -: art. no. e151 [J].
Baum, M ;
Bielau, S ;
Rittner, N ;
Schmid, K ;
Eggelbusch, K ;
Dahms, M ;
Schlauersbach, A ;
Tahedl, H ;
Beier, M ;
Güimil, R ;
Scheffler, M ;
Hermann, C ;
Funk, JM ;
Wixmerten, A ;
Rebscher, H ;
Hönig, M ;
Andreae, C ;
Büchner, D ;
Moschel, E ;
Glathe, A ;
Jäger, E ;
Thom, M ;
Greil, A ;
Bestvater, F ;
Obermeier, F ;
Burgmaier, J ;
Thome, K ;
Weichert, S ;
Hein, S ;
Binnewies, T ;
Foitzik, V ;
Müller, M ;
Stähler, CF ;
Stähler, PF .
NUCLEIC ACIDS RESEARCH, 2003, 31 (23) :e151
[5]   Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy [J].
Bertucci, F ;
Finetti, P ;
Rougemont, J ;
Charafe-Jauffret, E ;
Nasser, V ;
Loriod, W ;
Camerlo, J ;
Tagett, R ;
Tarpin, C ;
Houvenaeghel, G ;
Nguyen, C ;
Maraninchi, D ;
Jacquemier, J ;
Houlgatte, R ;
Birnbaum, D ;
Viens, P .
CANCER RESEARCH, 2004, 64 (23) :8558-8565
[6]   Oncogenic pathway signatures in human cancers as a guide to targeted therapies [J].
Bild, AH ;
Yao, G ;
Chang, JT ;
Wang, QL ;
Potti, A ;
Chasse, D ;
Joshi, MB ;
Harpole, D ;
Lancaster, JM ;
Berchuck, A ;
Olson, JA ;
Marks, JR ;
Dressman, HK ;
West, M ;
Nevins, JR .
NATURE, 2006, 439 (7074) :353-357
[7]   Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer [J].
Buyse, Marc ;
Loi, Sherene ;
van't Veer, Laura ;
Viale, Giuseppe ;
Delorenzi, Mauro ;
Glas, Annuska M. ;
d'Assignies, Mahasti Saghatchian ;
Bergh, Jonas ;
Lidereau, Rosette ;
Ellis, Paul ;
Harris, Adrian ;
Bogaerts, Jan ;
Therasse, Patrick ;
Floore, Arno ;
Amakrane, Mohamed ;
Piette, Fanny ;
Rutgers, Emiel ;
Sotiriou, Christos ;
Cardoso, Fatima ;
Piccart, Martine J. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (17) :1183-1192
[8]   Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival [J].
Chang, HY ;
Nuyten, DSA ;
Sneddon, JB ;
Hastie, T ;
Tibshirani, R ;
Sorlie, T ;
Dai, HY ;
He, YDD ;
van't Veer, LJ ;
Bartelink, H ;
van de Rijn, M ;
Brown, PO ;
van de Vijver, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (10) :3738-3743
[9]   Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds [J].
Chang, HY ;
Sneddon, JB ;
Alizadeh, AA ;
Sood, R ;
West, RB ;
Montgomery, K ;
Chi, JT ;
van de Rijn, M ;
Botstein, D ;
Brown, PO .
PLOS BIOLOGY, 2004, 2 (02) :206-214
[10]   Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients [J].
Chang, JC ;
Wooten, EC ;
Tsimelzon, A ;
Hilsenbeck, SG ;
Gutierrez, MC ;
Tham, YL ;
Kalidas, M ;
Elledge, R ;
Mohsin, S ;
Osborne, CK ;
Chamness, GC ;
Allred, DC ;
Lewis, MT ;
Wong, H ;
O'Connell, P .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) :1169-1177